Xiaozhou Yu

A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocelluar carcinoma

Xiaozhou Yu, Hua Zhao, Liang Liu et al. · Journal of Clinical Immunology · 2013 · 82 citations

Life Sciences, Immunology, Oncology +16

Enhanced glucose metabolism mediated by CD147 contributes to immunosuppression in hepatocellular carcinoma

Xiaofeng Li, Yufan Zhang, Wenchao Ma et al. · Cancer Immunology Immunotherapy · 2020 · 50 citations · Full text

Medicine, Cell Biology, Oncology +16

CD73, a Promising Therapeutic Target of Diclofenac, Promotes Metastasis of Pancreatic Cancer through a Nucleotidase Independent Mechanism

Weishuai Liu, Xiaozhou Yu, Yudong Yuan et al. · Advanced Science · 2022 · 38 citations · Full text

Medicine, Oncology, Pharmacology +12

CD73 induces gemcitabine resistance in pancreatic ductal adenocarcinoma: A promising target with non-canonical mechanisms

Xiaozhou Yu, Weishuai Liu, Ziyang Wang et al. · Cancer Letters · 2021 · 33 citations

Medicine, Cancer Biology, Oncology +10

MicroRNA‐520c‐3p functions as a novel tumor suppressor in lung adenocarcinoma

Xiaofeng Li, Qiang Fu, Hui Li et al. · FEBS Journal · 2019 · 32 citations · Full text

Life Sciences, Molecular Biology, Oncology +17